nodes	percent_of_prediction	percent_of_DWPC	metapath
Doxepin—CYP1A2—Leflunomide—systemic lupus erythematosus	0.0394	0.0776	CbGbCtD
Doxepin—CYP2C9—Leflunomide—systemic lupus erythematosus	0.0355	0.0699	CbGbCtD
Doxepin—CYP2C19—Dapsone—systemic lupus erythematosus	0.0304	0.0599	CbGbCtD
Doxepin—ABCB1—Methylprednisolone—systemic lupus erythematosus	0.0281	0.0553	CbGbCtD
Doxepin—CYP2C9—Dapsone—systemic lupus erythematosus	0.0253	0.0498	CbGbCtD
Doxepin—ABCB1—Mycophenolate mofetil—systemic lupus erythematosus	0.0213	0.0419	CbGbCtD
Doxepin—CYP2C19—Prednisone—systemic lupus erythematosus	0.0211	0.0415	CbGbCtD
Doxepin—CYP2C19—Cyclosporine—systemic lupus erythematosus	0.02	0.0394	CbGbCtD
Doxepin—ABCB1—Betamethasone—systemic lupus erythematosus	0.0182	0.036	CbGbCtD
Doxepin—ABCB1—Prednisolone—systemic lupus erythematosus	0.018	0.0355	CbGbCtD
Doxepin—ABCB1—Hydrocortisone—systemic lupus erythematosus	0.0171	0.0336	CbGbCtD
Doxepin—ABCB1—Prednisone—systemic lupus erythematosus	0.017	0.0335	CbGbCtD
Doxepin—HTR2B—cardial valve—systemic lupus erythematosus	0.0168	0.127	CbGeAlD
Doxepin—CYP3A4—Methylprednisolone—systemic lupus erythematosus	0.0168	0.0331	CbGbCtD
Doxepin—CYP2C9—Cyclosporine—systemic lupus erythematosus	0.0166	0.0327	CbGbCtD
Doxepin—ABCB1—Cyclosporine—systemic lupus erythematosus	0.0161	0.0318	CbGbCtD
Doxepin—CYP2D6—Cyclosporine—systemic lupus erythematosus	0.0152	0.0299	CbGbCtD
Doxepin—CYP3A4—Dapsone—systemic lupus erythematosus	0.0147	0.029	CbGbCtD
Doxepin—HTR2C—choroid plexus—systemic lupus erythematosus	0.0144	0.109	CbGeAlD
Doxepin—CYP2C19—Dexamethasone—systemic lupus erythematosus	0.0132	0.0259	CbGbCtD
Doxepin—CYP3A4—Mycophenolate mofetil—systemic lupus erythematosus	0.0127	0.0251	CbGbCtD
Doxepin—CYP3A4—Triamcinolone—systemic lupus erythematosus	0.0127	0.0251	CbGbCtD
Doxepin—CYP2C9—Dexamethasone—systemic lupus erythematosus	0.0109	0.0215	CbGbCtD
Doxepin—CYP3A4—Betamethasone—systemic lupus erythematosus	0.0109	0.0215	CbGbCtD
Doxepin—CYP2C9—cardial valve—systemic lupus erythematosus	0.0109	0.0824	CbGeAlD
Doxepin—CYP3A4—Prednisolone—systemic lupus erythematosus	0.0108	0.0213	CbGbCtD
Doxepin—ABCB1—Dexamethasone—systemic lupus erythematosus	0.0106	0.0209	CbGbCtD
Doxepin—CYP3A4—Hydrocortisone—systemic lupus erythematosus	0.0102	0.0201	CbGbCtD
Doxepin—CYP3A4—Prednisone—systemic lupus erythematosus	0.0102	0.0201	CbGbCtD
Doxepin—CYP2D6—Dexamethasone—systemic lupus erythematosus	0.01	0.0197	CbGbCtD
Doxepin—CYP3A4—Cyclosporine—systemic lupus erythematosus	0.00966	0.019	CbGbCtD
Doxepin—ABCB1—Methotrexate—systemic lupus erythematosus	0.00853	0.0168	CbGbCtD
Doxepin—HTR2A—choroid plexus—systemic lupus erythematosus	0.00725	0.0547	CbGeAlD
Doxepin—CYP3A4—Dexamethasone—systemic lupus erythematosus	0.00636	0.0125	CbGbCtD
Doxepin—CYP2C19—urine—systemic lupus erythematosus	0.00304	0.0229	CbGeAlD
Doxepin—HRH4—bone marrow—systemic lupus erythematosus	0.0027	0.0203	CbGeAlD
Doxepin—CYP1A2—urine—systemic lupus erythematosus	0.00248	0.0187	CbGeAlD
Doxepin—CYP2C9—urine—systemic lupus erythematosus	0.00235	0.0178	CbGeAlD
Doxepin—HTR2A—urine—systemic lupus erythematosus	0.00194	0.0146	CbGeAlD
Doxepin—SLC6A4—blood plasma—systemic lupus erythematosus	0.00191	0.0144	CbGeAlD
Doxepin—CYP3A4—urine—systemic lupus erythematosus	0.0018	0.0135	CbGeAlD
Doxepin—CYP2D6—urine—systemic lupus erythematosus	0.00177	0.0133	CbGeAlD
Doxepin—HTR1A—blood plasma—systemic lupus erythematosus	0.0017	0.0128	CbGeAlD
Doxepin—CYP2C19—blood plasma—systemic lupus erythematosus	0.00158	0.012	CbGeAlD
Doxepin—HRH2—skin of body—systemic lupus erythematosus	0.00153	0.0116	CbGeAlD
Doxepin—CHRM5—skin of body—systemic lupus erythematosus	0.00147	0.0111	CbGeAlD
Doxepin—CYP1A2—blood plasma—systemic lupus erythematosus	0.00129	0.00977	CbGeAlD
Doxepin—ADRA1B—kidney—systemic lupus erythematosus	0.00126	0.00953	CbGeAlD
Doxepin—CYP2C9—blood plasma—systemic lupus erythematosus	0.00123	0.00927	CbGeAlD
Doxepin—ADRA2A—blood plasma—systemic lupus erythematosus	0.00119	0.00898	CbGeAlD
Doxepin—CHRM4—nervous system—systemic lupus erythematosus	0.00116	0.00876	CbGeAlD
Doxepin—HTR2A—endothelium—systemic lupus erythematosus	0.00114	0.0086	CbGeAlD
Doxepin—CHRM4—central nervous system—systemic lupus erythematosus	0.00112	0.00843	CbGeAlD
Doxepin—HTR6—nervous system—systemic lupus erythematosus	0.00104	0.00784	CbGeAlD
Doxepin—HRH2—lung—systemic lupus erythematosus	0.00103	0.00774	CbGeAlD
Doxepin—HTR2A—blood plasma—systemic lupus erythematosus	0.00101	0.00764	CbGeAlD
Doxepin—HTR6—central nervous system—systemic lupus erythematosus	0.001	0.00754	CbGeAlD
Doxepin—HRH2—nervous system—systemic lupus erythematosus	0.000949	0.00716	CbGeAlD
Doxepin—CYP3A4—blood plasma—systemic lupus erythematosus	0.000937	0.00707	CbGeAlD
Doxepin—CYP2D6—blood plasma—systemic lupus erythematosus	0.000922	0.00696	CbGeAlD
Doxepin—HRH2—central nervous system—systemic lupus erythematosus	0.000914	0.0069	CbGeAlD
Doxepin—HTR2B—skin of body—systemic lupus erythematosus	0.000911	0.00688	CbGeAlD
Doxepin—CHRM5—nervous system—systemic lupus erythematosus	0.000907	0.00684	CbGeAlD
Doxepin—CHRM5—central nervous system—systemic lupus erythematosus	0.000873	0.00659	CbGeAlD
Doxepin—HTR2B—cortex of kidney—systemic lupus erythematosus	0.000837	0.00631	CbGeAlD
Doxepin—ADRA1B—nervous system—systemic lupus erythematosus	0.000829	0.00625	CbGeAlD
Doxepin—ADRA1D—nervous system—systemic lupus erythematosus	0.000811	0.00612	CbGeAlD
Doxepin—ADRA1B—central nervous system—systemic lupus erythematosus	0.000798	0.00602	CbGeAlD
Doxepin—ORM1—bone marrow—systemic lupus erythematosus	0.000796	0.006	CbGeAlD
Doxepin—ADRA1D—central nervous system—systemic lupus erythematosus	0.00078	0.00589	CbGeAlD
Doxepin—CHRM3—kidney—systemic lupus erythematosus	0.000773	0.00583	CbGeAlD
Doxepin—ADRA2C—nephron tubule—systemic lupus erythematosus	0.000769	0.00581	CbGeAlD
Doxepin—ORM1—lung—systemic lupus erythematosus	0.000721	0.00544	CbGeAlD
Doxepin—HTR2B—tendon—systemic lupus erythematosus	0.000694	0.00523	CbGeAlD
Doxepin—ADRA2C—kidney—systemic lupus erythematosus	0.000676	0.0051	CbGeAlD
Doxepin—ORM1—nervous system—systemic lupus erythematosus	0.000668	0.00504	CbGeAlD
Doxepin—ABCB1—blood plasma—systemic lupus erythematosus	0.000663	0.005	CbGeAlD
Doxepin—ADRA2C—cortex of kidney—systemic lupus erythematosus	0.000658	0.00497	CbGeAlD
Doxepin—HRH1—connective tissue—systemic lupus erythematosus	0.000645	0.00487	CbGeAlD
Doxepin—ORM1—central nervous system—systemic lupus erythematosus	0.000643	0.00485	CbGeAlD
Doxepin—ADRA2A—connective tissue—systemic lupus erythematosus	0.000634	0.00478	CbGeAlD
Doxepin—CHRM2—nervous system—systemic lupus erythematosus	0.000622	0.0047	CbGeAlD
Doxepin—SLC6A4—lung—systemic lupus erythematosus	0.000614	0.00464	CbGeAlD
Doxepin—CHRM1—lung—systemic lupus erythematosus	0.000612	0.00462	CbGeAlD
Doxepin—ADRA1A—lymphoid tissue—systemic lupus erythematosus	0.000609	0.0046	CbGeAlD
Doxepin—HTR2B—lung—systemic lupus erythematosus	0.000609	0.00459	CbGeAlD
Doxepin—HTR2C—nervous system—systemic lupus erythematosus	0.0006	0.00453	CbGeAlD
Doxepin—CHRM2—central nervous system—systemic lupus erythematosus	0.000599	0.00452	CbGeAlD
Doxepin—HTR2C—central nervous system—systemic lupus erythematosus	0.000578	0.00436	CbGeAlD
Doxepin—SLC6A4—nervous system—systemic lupus erythematosus	0.000569	0.00429	CbGeAlD
Doxepin—CHRM1—nervous system—systemic lupus erythematosus	0.000567	0.00428	CbGeAlD
Doxepin—HTR2B—nervous system—systemic lupus erythematosus	0.000564	0.00425	CbGeAlD
Doxepin—SLC6A4—central nervous system—systemic lupus erythematosus	0.000548	0.00413	CbGeAlD
Doxepin—ADRA2C—tendon—systemic lupus erythematosus	0.000546	0.00412	CbGeAlD
Doxepin—CHRM1—central nervous system—systemic lupus erythematosus	0.000546	0.00412	CbGeAlD
Doxepin—HTR2B—central nervous system—systemic lupus erythematosus	0.000543	0.00409	CbGeAlD
Doxepin—SLC6A2—lung—systemic lupus erythematosus	0.000541	0.00408	CbGeAlD
Doxepin—HTR2A—connective tissue—systemic lupus erythematosus	0.000539	0.00407	CbGeAlD
Doxepin—KCNH2—bone marrow—systemic lupus erythematosus	0.000536	0.00404	CbGeAlD
Doxepin—ADRA2A—cortex of kidney—systemic lupus erythematosus	0.000525	0.00396	CbGeAlD
Doxepin—CHRM3—nervous system—systemic lupus erythematosus	0.000507	0.00383	CbGeAlD
Doxepin—HTR1A—nervous system—systemic lupus erythematosus	0.000505	0.00381	CbGeAlD
Doxepin—SLC6A2—nervous system—systemic lupus erythematosus	0.000501	0.00378	CbGeAlD
Doxepin—DRD2—lung—systemic lupus erythematosus	0.000493	0.00372	CbGeAlD
Doxepin—CHRM3—central nervous system—systemic lupus erythematosus	0.000488	0.00368	CbGeAlD
Doxepin—HTR1A—central nervous system—systemic lupus erythematosus	0.000486	0.00367	CbGeAlD
Doxepin—SLC6A2—central nervous system—systemic lupus erythematosus	0.000482	0.00364	CbGeAlD
Doxepin—ADRA2C—lung—systemic lupus erythematosus	0.000479	0.00362	CbGeAlD
Doxepin—ADRA1A—nervous system—systemic lupus erythematosus	0.000466	0.00351	CbGeAlD
Doxepin—HTR2A—kidney—systemic lupus erythematosus	0.000459	0.00346	CbGeAlD
Doxepin—DRD2—nervous system—systemic lupus erythematosus	0.000456	0.00344	CbGeAlD
Doxepin—KCNH2—nervous system—systemic lupus erythematosus	0.00045	0.00339	CbGeAlD
Doxepin—ADRA1A—central nervous system—systemic lupus erythematosus	0.000448	0.00338	CbGeAlD
Doxepin—ADRA2C—nervous system—systemic lupus erythematosus	0.000444	0.00335	CbGeAlD
Doxepin—HRH1—tendon—systemic lupus erythematosus	0.000443	0.00335	CbGeAlD
Doxepin—DRD2—central nervous system—systemic lupus erythematosus	0.000439	0.00332	CbGeAlD
Doxepin—ADRA2A—tendon—systemic lupus erythematosus	0.000436	0.00329	CbGeAlD
Doxepin—KCNH2—central nervous system—systemic lupus erythematosus	0.000433	0.00327	CbGeAlD
Doxepin—ADRA2C—central nervous system—systemic lupus erythematosus	0.000427	0.00322	CbGeAlD
Doxepin—CYP3A4—kidney—systemic lupus erythematosus	0.000425	0.0032	CbGeAlD
Doxepin—CYP2D6—kidney—systemic lupus erythematosus	0.000418	0.00315	CbGeAlD
Doxepin—CYP1A2—lung—systemic lupus erythematosus	0.000416	0.00314	CbGeAlD
Doxepin—HRH1—lung—systemic lupus erythematosus	0.000389	0.00294	CbGeAlD
Doxepin—ADRA2A—lung—systemic lupus erythematosus	0.000382	0.00288	CbGeAlD
Doxepin—HTR2A—tendon—systemic lupus erythematosus	0.00037	0.00279	CbGeAlD
Doxepin—HRH1—nervous system—systemic lupus erythematosus	0.00036	0.00272	CbGeAlD
Doxepin—ADRA2A—nervous system—systemic lupus erythematosus	0.000354	0.00267	CbGeAlD
Doxepin—HRH1—central nervous system—systemic lupus erythematosus	0.000347	0.00262	CbGeAlD
Doxepin—ABCB1—nephron tubule—systemic lupus erythematosus	0.000342	0.00258	CbGeAlD
Doxepin—ADRA2A—central nervous system—systemic lupus erythematosus	0.000341	0.00257	CbGeAlD
Doxepin—HTR2A—lung—systemic lupus erythematosus	0.000325	0.00245	CbGeAlD
Doxepin—HTR2A—nervous system—systemic lupus erythematosus	0.000301	0.00227	CbGeAlD
Doxepin—ABCB1—kidney—systemic lupus erythematosus	0.000301	0.00227	CbGeAlD
Doxepin—ABCB1—cortex of kidney—systemic lupus erythematosus	0.000293	0.00221	CbGeAlD
Doxepin—HTR2A—central nervous system—systemic lupus erythematosus	0.00029	0.00219	CbGeAlD
Doxepin—CYP3A4—nervous system—systemic lupus erythematosus	0.000279	0.0021	CbGeAlD
Doxepin—CYP2D6—nervous system—systemic lupus erythematosus	0.000274	0.00207	CbGeAlD
Doxepin—CYP3A4—central nervous system—systemic lupus erythematosus	0.000268	0.00202	CbGeAlD
Doxepin—CYP2D6—central nervous system—systemic lupus erythematosus	0.000264	0.00199	CbGeAlD
Doxepin—ABCB1—lymphoid tissue—systemic lupus erythematosus	0.000258	0.00195	CbGeAlD
Doxepin—ABCB1—bone marrow—systemic lupus erythematosus	0.000235	0.00177	CbGeAlD
Doxepin—ABCB1—lung—systemic lupus erythematosus	0.000213	0.00161	CbGeAlD
Doxepin—ABCB1—nervous system—systemic lupus erythematosus	0.000197	0.00149	CbGeAlD
Doxepin—ABCB1—central nervous system—systemic lupus erythematosus	0.00019	0.00143	CbGeAlD
Doxepin—Fatigue—Hydrocortisone—systemic lupus erythematosus	0.000143	0.000474	CcSEcCtD
Doxepin—Vision blurred—Prednisone—systemic lupus erythematosus	0.000142	0.000473	CcSEcCtD
Doxepin—Urethral disorder—Methotrexate—systemic lupus erythematosus	0.000142	0.000472	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Triamcinolone—systemic lupus erythematosus	0.000142	0.000472	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Methylprednisolone—systemic lupus erythematosus	0.000142	0.000471	CcSEcCtD
Doxepin—Pain—Hydrocortisone—systemic lupus erythematosus	0.000142	0.00047	CcSEcCtD
Doxepin—Oedema—Betamethasone—systemic lupus erythematosus	0.000142	0.00047	CcSEcCtD
Doxepin—Oedema—Dexamethasone—systemic lupus erythematosus	0.000142	0.00047	CcSEcCtD
Doxepin—Insomnia—Triamcinolone—systemic lupus erythematosus	0.000141	0.000468	CcSEcCtD
Doxepin—Insomnia—Methylprednisolone—systemic lupus erythematosus	0.000141	0.000467	CcSEcCtD
Doxepin—Infection—Betamethasone—systemic lupus erythematosus	0.000141	0.000467	CcSEcCtD
Doxepin—Infection—Dexamethasone—systemic lupus erythematosus	0.000141	0.000467	CcSEcCtD
Doxepin—Ill-defined disorder—Prednisone—systemic lupus erythematosus	0.00014	0.000465	CcSEcCtD
Doxepin—Paraesthesia—Triamcinolone—systemic lupus erythematosus	0.00014	0.000465	CcSEcCtD
Doxepin—Feeling abnormal—Prednisolone—systemic lupus erythematosus	0.00014	0.000464	CcSEcCtD
Doxepin—Paraesthesia—Methylprednisolone—systemic lupus erythematosus	0.00014	0.000464	CcSEcCtD
Doxepin—Anaemia—Prednisone—systemic lupus erythematosus	0.00014	0.000464	CcSEcCtD
Doxepin—Shock—Dexamethasone—systemic lupus erythematosus	0.000139	0.000462	CcSEcCtD
Doxepin—Shock—Betamethasone—systemic lupus erythematosus	0.000139	0.000462	CcSEcCtD
Doxepin—Dyspnoea—Triamcinolone—systemic lupus erythematosus	0.000139	0.000462	CcSEcCtD
Doxepin—Nervous system disorder—Betamethasone—systemic lupus erythematosus	0.000139	0.000461	CcSEcCtD
Doxepin—Nervous system disorder—Dexamethasone—systemic lupus erythematosus	0.000139	0.000461	CcSEcCtD
Doxepin—Agitation—Prednisone—systemic lupus erythematosus	0.000139	0.000461	CcSEcCtD
Doxepin—Thrombocytopenia—Dexamethasone—systemic lupus erythematosus	0.000139	0.00046	CcSEcCtD
Doxepin—Thrombocytopenia—Betamethasone—systemic lupus erythematosus	0.000139	0.00046	CcSEcCtD
Doxepin—Tachycardia—Betamethasone—systemic lupus erythematosus	0.000138	0.000459	CcSEcCtD
Doxepin—Tachycardia—Dexamethasone—systemic lupus erythematosus	0.000138	0.000459	CcSEcCtD
Doxepin—Hypersensitivity—Cyclosporine—systemic lupus erythematosus	0.000137	0.000456	CcSEcCtD
Doxepin—Dyspepsia—Triamcinolone—systemic lupus erythematosus	0.000137	0.000456	CcSEcCtD
Doxepin—Dyspepsia—Methylprednisolone—systemic lupus erythematosus	0.000137	0.000455	CcSEcCtD
Doxepin—Hyperhidrosis—Dexamethasone—systemic lupus erythematosus	0.000137	0.000454	CcSEcCtD
Doxepin—Hyperhidrosis—Betamethasone—systemic lupus erythematosus	0.000137	0.000454	CcSEcCtD
Doxepin—Feeling abnormal—Hydrocortisone—systemic lupus erythematosus	0.000137	0.000453	CcSEcCtD
Doxepin—Malaise—Prednisone—systemic lupus erythematosus	0.000136	0.000452	CcSEcCtD
Doxepin—Vertigo—Prednisone—systemic lupus erythematosus	0.000136	0.000451	CcSEcCtD
Doxepin—Eye disorder—Methotrexate—systemic lupus erythematosus	0.000136	0.00045	CcSEcCtD
Doxepin—Gastrointestinal pain—Hydrocortisone—systemic lupus erythematosus	0.000136	0.00045	CcSEcCtD
Doxepin—Syncope—Prednisone—systemic lupus erythematosus	0.000135	0.00045	CcSEcCtD
Doxepin—Tinnitus—Methotrexate—systemic lupus erythematosus	0.000135	0.000449	CcSEcCtD
Doxepin—Anorexia—Betamethasone—systemic lupus erythematosus	0.000135	0.000448	CcSEcCtD
Doxepin—Anorexia—Dexamethasone—systemic lupus erythematosus	0.000135	0.000448	CcSEcCtD
Doxepin—Urticaria—Prednisolone—systemic lupus erythematosus	0.000135	0.000447	CcSEcCtD
Doxepin—Cardiac disorder—Methotrexate—systemic lupus erythematosus	0.000135	0.000447	CcSEcCtD
Doxepin—Fatigue—Triamcinolone—systemic lupus erythematosus	0.000135	0.000447	CcSEcCtD
Doxepin—Fatigue—Methylprednisolone—systemic lupus erythematosus	0.000134	0.000446	CcSEcCtD
Doxepin—Hypersensitivity—Mycophenolate mofetil—systemic lupus erythematosus	0.000134	0.000445	CcSEcCtD
Doxepin—Asthenia—Cyclosporine—systemic lupus erythematosus	0.000134	0.000444	CcSEcCtD
Doxepin—Pain—Triamcinolone—systemic lupus erythematosus	0.000133	0.000443	CcSEcCtD
Doxepin—Loss of consciousness—Prednisone—systemic lupus erythematosus	0.000133	0.000441	CcSEcCtD
Doxepin—Hypotension—Betamethasone—systemic lupus erythematosus	0.000132	0.000439	CcSEcCtD
Doxepin—Hypotension—Dexamethasone—systemic lupus erythematosus	0.000132	0.000439	CcSEcCtD
Doxepin—Pruritus—Cyclosporine—systemic lupus erythematosus	0.000132	0.000438	CcSEcCtD
Doxepin—Urticaria—Hydrocortisone—systemic lupus erythematosus	0.000132	0.000437	CcSEcCtD
Doxepin—Angiopathy—Methotrexate—systemic lupus erythematosus	0.000132	0.000437	CcSEcCtD
Doxepin—Immune system disorder—Methotrexate—systemic lupus erythematosus	0.000131	0.000435	CcSEcCtD
Doxepin—Abdominal pain—Hydrocortisone—systemic lupus erythematosus	0.000131	0.000435	CcSEcCtD
Doxepin—Body temperature increased—Hydrocortisone—systemic lupus erythematosus	0.000131	0.000435	CcSEcCtD
Doxepin—Convulsion—Prednisone—systemic lupus erythematosus	0.000131	0.000434	CcSEcCtD
Doxepin—Mediastinal disorder—Methotrexate—systemic lupus erythematosus	0.000131	0.000434	CcSEcCtD
Doxepin—Asthenia—Mycophenolate mofetil—systemic lupus erythematosus	0.000131	0.000433	CcSEcCtD
Doxepin—Hypertension—Prednisone—systemic lupus erythematosus	0.00013	0.000433	CcSEcCtD
Doxepin—Chills—Methotrexate—systemic lupus erythematosus	0.00013	0.000432	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Dexamethasone—systemic lupus erythematosus	0.000129	0.000428	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Betamethasone—systemic lupus erythematosus	0.000129	0.000428	CcSEcCtD
Doxepin—Pruritus—Mycophenolate mofetil—systemic lupus erythematosus	0.000129	0.000427	CcSEcCtD
Doxepin—Myalgia—Prednisone—systemic lupus erythematosus	0.000129	0.000427	CcSEcCtD
Doxepin—Arthralgia—Prednisone—systemic lupus erythematosus	0.000129	0.000427	CcSEcCtD
Doxepin—Feeling abnormal—Triamcinolone—systemic lupus erythematosus	0.000129	0.000427	CcSEcCtD
Doxepin—Feeling abnormal—Methylprednisolone—systemic lupus erythematosus	0.000128	0.000426	CcSEcCtD
Doxepin—Anxiety—Prednisone—systemic lupus erythematosus	0.000128	0.000425	CcSEcCtD
Doxepin—Alopecia—Methotrexate—systemic lupus erythematosus	0.000128	0.000425	CcSEcCtD
Doxepin—Insomnia—Betamethasone—systemic lupus erythematosus	0.000128	0.000425	CcSEcCtD
Doxepin—Insomnia—Dexamethasone—systemic lupus erythematosus	0.000128	0.000425	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Prednisone—systemic lupus erythematosus	0.000128	0.000424	CcSEcCtD
Doxepin—Diarrhoea—Cyclosporine—systemic lupus erythematosus	0.000128	0.000423	CcSEcCtD
Doxepin—Gastrointestinal pain—Methylprednisolone—systemic lupus erythematosus	0.000127	0.000423	CcSEcCtD
Doxepin—Paraesthesia—Dexamethasone—systemic lupus erythematosus	0.000127	0.000422	CcSEcCtD
Doxepin—Paraesthesia—Betamethasone—systemic lupus erythematosus	0.000127	0.000422	CcSEcCtD
Doxepin—Discomfort—Prednisone—systemic lupus erythematosus	0.000127	0.000422	CcSEcCtD
Doxepin—Mental disorder—Methotrexate—systemic lupus erythematosus	0.000127	0.000422	CcSEcCtD
Doxepin—Erythema—Methotrexate—systemic lupus erythematosus	0.000126	0.000419	CcSEcCtD
Doxepin—Malnutrition—Methotrexate—systemic lupus erythematosus	0.000126	0.000419	CcSEcCtD
Doxepin—Hypersensitivity—Prednisolone—systemic lupus erythematosus	0.000125	0.000415	CcSEcCtD
Doxepin—Dyspepsia—Betamethasone—systemic lupus erythematosus	0.000125	0.000414	CcSEcCtD
Doxepin—Dyspepsia—Dexamethasone—systemic lupus erythematosus	0.000125	0.000414	CcSEcCtD
Doxepin—Diarrhoea—Mycophenolate mofetil—systemic lupus erythematosus	0.000124	0.000413	CcSEcCtD
Doxepin—Urticaria—Triamcinolone—systemic lupus erythematosus	0.000124	0.000411	CcSEcCtD
Doxepin—Urticaria—Methylprednisolone—systemic lupus erythematosus	0.000124	0.000411	CcSEcCtD
Doxepin—Dysgeusia—Methotrexate—systemic lupus erythematosus	0.000124	0.00041	CcSEcCtD
Doxepin—Body temperature increased—Triamcinolone—systemic lupus erythematosus	0.000123	0.000409	CcSEcCtD
Doxepin—Dizziness—Cyclosporine—systemic lupus erythematosus	0.000123	0.000409	CcSEcCtD
Doxepin—Oedema—Prednisone—systemic lupus erythematosus	0.000123	0.000409	CcSEcCtD
Doxepin—Abdominal pain—Methylprednisolone—systemic lupus erythematosus	0.000123	0.000409	CcSEcCtD
Doxepin—Decreased appetite—Dexamethasone—systemic lupus erythematosus	0.000123	0.000409	CcSEcCtD
Doxepin—Decreased appetite—Betamethasone—systemic lupus erythematosus	0.000123	0.000409	CcSEcCtD
Doxepin—Infection—Prednisone—systemic lupus erythematosus	0.000123	0.000407	CcSEcCtD
Doxepin—Gastrointestinal disorder—Betamethasone—systemic lupus erythematosus	0.000122	0.000406	CcSEcCtD
Doxepin—Gastrointestinal disorder—Dexamethasone—systemic lupus erythematosus	0.000122	0.000406	CcSEcCtD
Doxepin—Back pain—Methotrexate—systemic lupus erythematosus	0.000122	0.000405	CcSEcCtD
Doxepin—Hypersensitivity—Hydrocortisone—systemic lupus erythematosus	0.000122	0.000405	CcSEcCtD
Doxepin—Fatigue—Dexamethasone—systemic lupus erythematosus	0.000122	0.000405	CcSEcCtD
Doxepin—Fatigue—Betamethasone—systemic lupus erythematosus	0.000122	0.000405	CcSEcCtD
Doxepin—Shock—Prednisone—systemic lupus erythematosus	0.000121	0.000403	CcSEcCtD
Doxepin—Pain—Dexamethasone—systemic lupus erythematosus	0.000121	0.000402	CcSEcCtD
Doxepin—Pain—Betamethasone—systemic lupus erythematosus	0.000121	0.000402	CcSEcCtD
Doxepin—Nervous system disorder—Prednisone—systemic lupus erythematosus	0.000121	0.000401	CcSEcCtD
Doxepin—Tachycardia—Prednisone—systemic lupus erythematosus	0.00012	0.000399	CcSEcCtD
Doxepin—Dizziness—Mycophenolate mofetil—systemic lupus erythematosus	0.00012	0.000399	CcSEcCtD
Doxepin—Skin disorder—Prednisone—systemic lupus erythematosus	0.00012	0.000398	CcSEcCtD
Doxepin—Hyperhidrosis—Prednisone—systemic lupus erythematosus	0.000119	0.000396	CcSEcCtD
Doxepin—Vision blurred—Methotrexate—systemic lupus erythematosus	0.000119	0.000395	CcSEcCtD
Doxepin—Asthenia—Hydrocortisone—systemic lupus erythematosus	0.000119	0.000395	CcSEcCtD
Doxepin—Vomiting—Cyclosporine—systemic lupus erythematosus	0.000119	0.000394	CcSEcCtD
Doxepin—Rash—Cyclosporine—systemic lupus erythematosus	0.000118	0.00039	CcSEcCtD
Doxepin—Anorexia—Prednisone—systemic lupus erythematosus	0.000118	0.00039	CcSEcCtD
Doxepin—Dermatitis—Cyclosporine—systemic lupus erythematosus	0.000117	0.00039	CcSEcCtD
Doxepin—Pruritus—Hydrocortisone—systemic lupus erythematosus	0.000117	0.000389	CcSEcCtD
Doxepin—Ill-defined disorder—Methotrexate—systemic lupus erythematosus	0.000117	0.000389	CcSEcCtD
Doxepin—Headache—Cyclosporine—systemic lupus erythematosus	0.000117	0.000388	CcSEcCtD
Doxepin—Anaemia—Methotrexate—systemic lupus erythematosus	0.000117	0.000387	CcSEcCtD
Doxepin—Feeling abnormal—Betamethasone—systemic lupus erythematosus	0.000117	0.000387	CcSEcCtD
Doxepin—Feeling abnormal—Dexamethasone—systemic lupus erythematosus	0.000117	0.000387	CcSEcCtD
Doxepin—Gastrointestinal pain—Betamethasone—systemic lupus erythematosus	0.000116	0.000384	CcSEcCtD
Doxepin—Gastrointestinal pain—Dexamethasone—systemic lupus erythematosus	0.000116	0.000384	CcSEcCtD
Doxepin—Vomiting—Mycophenolate mofetil—systemic lupus erythematosus	0.000116	0.000384	CcSEcCtD
Doxepin—Hypersensitivity—Triamcinolone—systemic lupus erythematosus	0.000115	0.000382	CcSEcCtD
Doxepin—Hypersensitivity—Methylprednisolone—systemic lupus erythematosus	0.000115	0.000381	CcSEcCtD
Doxepin—Rash—Mycophenolate mofetil—systemic lupus erythematosus	0.000115	0.000381	CcSEcCtD
Doxepin—Dermatitis—Mycophenolate mofetil—systemic lupus erythematosus	0.000115	0.00038	CcSEcCtD
Doxepin—Headache—Mycophenolate mofetil—systemic lupus erythematosus	0.000114	0.000378	CcSEcCtD
Doxepin—Malaise—Methotrexate—systemic lupus erythematosus	0.000114	0.000378	CcSEcCtD
Doxepin—Vertigo—Methotrexate—systemic lupus erythematosus	0.000113	0.000377	CcSEcCtD
Doxepin—Diarrhoea—Hydrocortisone—systemic lupus erythematosus	0.000113	0.000376	CcSEcCtD
Doxepin—Leukopenia—Methotrexate—systemic lupus erythematosus	0.000113	0.000375	CcSEcCtD
Doxepin—Urticaria—Betamethasone—systemic lupus erythematosus	0.000112	0.000373	CcSEcCtD
Doxepin—Urticaria—Dexamethasone—systemic lupus erythematosus	0.000112	0.000373	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Prednisone—systemic lupus erythematosus	0.000112	0.000373	CcSEcCtD
Doxepin—Dizziness—Prednisolone—systemic lupus erythematosus	0.000112	0.000372	CcSEcCtD
Doxepin—Asthenia—Triamcinolone—systemic lupus erythematosus	0.000112	0.000372	CcSEcCtD
Doxepin—Abdominal pain—Dexamethasone—systemic lupus erythematosus	0.000112	0.000372	CcSEcCtD
Doxepin—Body temperature increased—Betamethasone—systemic lupus erythematosus	0.000112	0.000372	CcSEcCtD
Doxepin—Body temperature increased—Dexamethasone—systemic lupus erythematosus	0.000112	0.000372	CcSEcCtD
Doxepin—Abdominal pain—Betamethasone—systemic lupus erythematosus	0.000112	0.000372	CcSEcCtD
Doxepin—Asthenia—Methylprednisolone—systemic lupus erythematosus	0.000112	0.000371	CcSEcCtD
Doxepin—Insomnia—Prednisone—systemic lupus erythematosus	0.000112	0.00037	CcSEcCtD
Doxepin—Nausea—Cyclosporine—systemic lupus erythematosus	0.000111	0.000368	CcSEcCtD
Doxepin—Paraesthesia—Prednisone—systemic lupus erythematosus	0.000111	0.000368	CcSEcCtD
Doxepin—Pruritus—Triamcinolone—systemic lupus erythematosus	0.00011	0.000366	CcSEcCtD
Doxepin—Cough—Methotrexate—systemic lupus erythematosus	0.00011	0.000366	CcSEcCtD
Doxepin—Pruritus—Methylprednisolone—systemic lupus erythematosus	0.00011	0.000366	CcSEcCtD
Doxepin—Dizziness—Hydrocortisone—systemic lupus erythematosus	0.00011	0.000364	CcSEcCtD
Doxepin—Convulsion—Methotrexate—systemic lupus erythematosus	0.000109	0.000363	CcSEcCtD
Doxepin—Dyspepsia—Prednisone—systemic lupus erythematosus	0.000109	0.00036	CcSEcCtD
Doxepin—Nausea—Mycophenolate mofetil—systemic lupus erythematosus	0.000108	0.000359	CcSEcCtD
Doxepin—Myalgia—Methotrexate—systemic lupus erythematosus	0.000108	0.000357	CcSEcCtD
Doxepin—Chest pain—Methotrexate—systemic lupus erythematosus	0.000108	0.000357	CcSEcCtD
Doxepin—Arthralgia—Methotrexate—systemic lupus erythematosus	0.000108	0.000357	CcSEcCtD
Doxepin—Decreased appetite—Prednisone—systemic lupus erythematosus	0.000107	0.000356	CcSEcCtD
Doxepin—Rash—Prednisolone—systemic lupus erythematosus	0.000107	0.000355	CcSEcCtD
Doxepin—Dermatitis—Prednisolone—systemic lupus erythematosus	0.000107	0.000355	CcSEcCtD
Doxepin—Unspecified disorder of skin and subcutaneous tissue—Methotrexate—systemic lupus erythematosus	0.000107	0.000354	CcSEcCtD
Doxepin—Diarrhoea—Methylprednisolone—systemic lupus erythematosus	0.000107	0.000354	CcSEcCtD
Doxepin—Fatigue—Prednisone—systemic lupus erythematosus	0.000106	0.000353	CcSEcCtD
Doxepin—Headache—Prednisolone—systemic lupus erythematosus	0.000106	0.000353	CcSEcCtD
Doxepin—Discomfort—Methotrexate—systemic lupus erythematosus	0.000106	0.000353	CcSEcCtD
Doxepin—Constipation—Prednisone—systemic lupus erythematosus	0.000105	0.00035	CcSEcCtD
Doxepin—Vomiting—Hydrocortisone—systemic lupus erythematosus	0.000105	0.00035	CcSEcCtD
Doxepin—Rash—Hydrocortisone—systemic lupus erythematosus	0.000104	0.000347	CcSEcCtD
Doxepin—Dermatitis—Hydrocortisone—systemic lupus erythematosus	0.000104	0.000347	CcSEcCtD
Doxepin—Confusional state—Methotrexate—systemic lupus erythematosus	0.000104	0.000345	CcSEcCtD
Doxepin—Headache—Hydrocortisone—systemic lupus erythematosus	0.000104	0.000345	CcSEcCtD
Doxepin—Dizziness—Triamcinolone—systemic lupus erythematosus	0.000103	0.000343	CcSEcCtD
Doxepin—Dizziness—Methylprednisolone—systemic lupus erythematosus	0.000103	0.000342	CcSEcCtD
Doxepin—Infection—Methotrexate—systemic lupus erythematosus	0.000102	0.00034	CcSEcCtD
Doxepin—Feeling abnormal—Prednisone—systemic lupus erythematosus	0.000102	0.000337	CcSEcCtD
Doxepin—Asthenia—Betamethasone—systemic lupus erythematosus	0.000102	0.000337	CcSEcCtD
Doxepin—Asthenia—Dexamethasone—systemic lupus erythematosus	0.000102	0.000337	CcSEcCtD
Doxepin—Nervous system disorder—Methotrexate—systemic lupus erythematosus	0.000101	0.000335	CcSEcCtD
Doxepin—Thrombocytopenia—Methotrexate—systemic lupus erythematosus	0.000101	0.000335	CcSEcCtD
Doxepin—Gastrointestinal pain—Prednisone—systemic lupus erythematosus	0.000101	0.000335	CcSEcCtD
Doxepin—Nausea—Prednisolone—systemic lupus erythematosus	0.000101	0.000335	CcSEcCtD
Doxepin—Pruritus—Dexamethasone—systemic lupus erythematosus	0.0001	0.000332	CcSEcCtD
Doxepin—Pruritus—Betamethasone—systemic lupus erythematosus	0.0001	0.000332	CcSEcCtD
Doxepin—Skin disorder—Methotrexate—systemic lupus erythematosus	0.0001	0.000332	CcSEcCtD
Doxepin—Hyperhidrosis—Methotrexate—systemic lupus erythematosus	9.96e-05	0.000331	CcSEcCtD
Doxepin—Vomiting—Triamcinolone—systemic lupus erythematosus	9.92e-05	0.000329	CcSEcCtD
Doxepin—Vomiting—Methylprednisolone—systemic lupus erythematosus	9.9e-05	0.000329	CcSEcCtD
Doxepin—Nausea—Hydrocortisone—systemic lupus erythematosus	9.84e-05	0.000327	CcSEcCtD
Doxepin—Rash—Triamcinolone—systemic lupus erythematosus	9.84e-05	0.000327	CcSEcCtD
Doxepin—Dermatitis—Triamcinolone—systemic lupus erythematosus	9.83e-05	0.000326	CcSEcCtD
Doxepin—Anorexia—Methotrexate—systemic lupus erythematosus	9.82e-05	0.000326	CcSEcCtD
Doxepin—Rash—Methylprednisolone—systemic lupus erythematosus	9.82e-05	0.000326	CcSEcCtD
Doxepin—Dermatitis—Methylprednisolone—systemic lupus erythematosus	9.81e-05	0.000326	CcSEcCtD
Doxepin—Urticaria—Prednisone—systemic lupus erythematosus	9.8e-05	0.000325	CcSEcCtD
Doxepin—Headache—Triamcinolone—systemic lupus erythematosus	9.78e-05	0.000324	CcSEcCtD
Doxepin—Headache—Methylprednisolone—systemic lupus erythematosus	9.75e-05	0.000324	CcSEcCtD
Doxepin—Abdominal pain—Prednisone—systemic lupus erythematosus	9.75e-05	0.000324	CcSEcCtD
Doxepin—Body temperature increased—Prednisone—systemic lupus erythematosus	9.75e-05	0.000324	CcSEcCtD
Doxepin—Diarrhoea—Dexamethasone—systemic lupus erythematosus	9.69e-05	0.000322	CcSEcCtD
Doxepin—Diarrhoea—Betamethasone—systemic lupus erythematosus	9.69e-05	0.000322	CcSEcCtD
Doxepin—Hypotension—Methotrexate—systemic lupus erythematosus	9.63e-05	0.00032	CcSEcCtD
Doxepin—Musculoskeletal discomfort—Methotrexate—systemic lupus erythematosus	9.39e-05	0.000312	CcSEcCtD
Doxepin—Dizziness—Betamethasone—systemic lupus erythematosus	9.36e-05	0.000311	CcSEcCtD
Doxepin—Dizziness—Dexamethasone—systemic lupus erythematosus	9.36e-05	0.000311	CcSEcCtD
Doxepin—Insomnia—Methotrexate—systemic lupus erythematosus	9.32e-05	0.000309	CcSEcCtD
Doxepin—Nausea—Triamcinolone—systemic lupus erythematosus	9.27e-05	0.000308	CcSEcCtD
Doxepin—Paraesthesia—Methotrexate—systemic lupus erythematosus	9.25e-05	0.000307	CcSEcCtD
Doxepin—Nausea—Methylprednisolone—systemic lupus erythematosus	9.25e-05	0.000307	CcSEcCtD
Doxepin—Dyspnoea—Methotrexate—systemic lupus erythematosus	9.19e-05	0.000305	CcSEcCtD
Doxepin—Somnolence—Methotrexate—systemic lupus erythematosus	9.16e-05	0.000304	CcSEcCtD
Doxepin—Hypersensitivity—Prednisone—systemic lupus erythematosus	9.09e-05	0.000302	CcSEcCtD
Doxepin—Dyspepsia—Methotrexate—systemic lupus erythematosus	9.07e-05	0.000301	CcSEcCtD
Doxepin—Vomiting—Dexamethasone—systemic lupus erythematosus	9e-05	0.000299	CcSEcCtD
Doxepin—Vomiting—Betamethasone—systemic lupus erythematosus	9e-05	0.000299	CcSEcCtD
Doxepin—Decreased appetite—Methotrexate—systemic lupus erythematosus	8.96e-05	0.000297	CcSEcCtD
Doxepin—Rash—Dexamethasone—systemic lupus erythematosus	8.93e-05	0.000296	CcSEcCtD
Doxepin—Rash—Betamethasone—systemic lupus erythematosus	8.93e-05	0.000296	CcSEcCtD
Doxepin—Dermatitis—Dexamethasone—systemic lupus erythematosus	8.92e-05	0.000296	CcSEcCtD
Doxepin—Dermatitis—Betamethasone—systemic lupus erythematosus	8.92e-05	0.000296	CcSEcCtD
Doxepin—Gastrointestinal disorder—Methotrexate—systemic lupus erythematosus	8.9e-05	0.000295	CcSEcCtD
Doxepin—Fatigue—Methotrexate—systemic lupus erythematosus	8.89e-05	0.000295	CcSEcCtD
Doxepin—Headache—Betamethasone—systemic lupus erythematosus	8.87e-05	0.000294	CcSEcCtD
Doxepin—Headache—Dexamethasone—systemic lupus erythematosus	8.87e-05	0.000294	CcSEcCtD
Doxepin—Asthenia—Prednisone—systemic lupus erythematosus	8.85e-05	0.000294	CcSEcCtD
Doxepin—Pain—Methotrexate—systemic lupus erythematosus	8.81e-05	0.000292	CcSEcCtD
Doxepin—Pruritus—Prednisone—systemic lupus erythematosus	8.72e-05	0.00029	CcSEcCtD
Doxepin—Feeling abnormal—Methotrexate—systemic lupus erythematosus	8.49e-05	0.000282	CcSEcCtD
Doxepin—Diarrhoea—Prednisone—systemic lupus erythematosus	8.44e-05	0.00028	CcSEcCtD
Doxepin—Gastrointestinal pain—Methotrexate—systemic lupus erythematosus	8.43e-05	0.00028	CcSEcCtD
Doxepin—Nausea—Betamethasone—systemic lupus erythematosus	8.41e-05	0.000279	CcSEcCtD
Doxepin—Nausea—Dexamethasone—systemic lupus erythematosus	8.41e-05	0.000279	CcSEcCtD
Doxepin—Urticaria—Methotrexate—systemic lupus erythematosus	8.19e-05	0.000272	CcSEcCtD
Doxepin—Dizziness—Prednisone—systemic lupus erythematosus	8.15e-05	0.000271	CcSEcCtD
Doxepin—Abdominal pain—Methotrexate—systemic lupus erythematosus	8.15e-05	0.00027	CcSEcCtD
Doxepin—Body temperature increased—Methotrexate—systemic lupus erythematosus	8.15e-05	0.00027	CcSEcCtD
Doxepin—Vomiting—Prednisone—systemic lupus erythematosus	7.84e-05	0.00026	CcSEcCtD
Doxepin—Rash—Prednisone—systemic lupus erythematosus	7.78e-05	0.000258	CcSEcCtD
Doxepin—Dermatitis—Prednisone—systemic lupus erythematosus	7.77e-05	0.000258	CcSEcCtD
Doxepin—Headache—Prednisone—systemic lupus erythematosus	7.73e-05	0.000256	CcSEcCtD
Doxepin—Hypersensitivity—Methotrexate—systemic lupus erythematosus	7.59e-05	0.000252	CcSEcCtD
Doxepin—Asthenia—Methotrexate—systemic lupus erythematosus	7.39e-05	0.000245	CcSEcCtD
Doxepin—Nausea—Prednisone—systemic lupus erythematosus	7.32e-05	0.000243	CcSEcCtD
Doxepin—Pruritus—Methotrexate—systemic lupus erythematosus	7.29e-05	0.000242	CcSEcCtD
Doxepin—Diarrhoea—Methotrexate—systemic lupus erythematosus	7.05e-05	0.000234	CcSEcCtD
Doxepin—Dizziness—Methotrexate—systemic lupus erythematosus	6.81e-05	0.000226	CcSEcCtD
Doxepin—Vomiting—Methotrexate—systemic lupus erythematosus	6.55e-05	0.000217	CcSEcCtD
Doxepin—Rash—Methotrexate—systemic lupus erythematosus	6.5e-05	0.000216	CcSEcCtD
Doxepin—Dermatitis—Methotrexate—systemic lupus erythematosus	6.49e-05	0.000215	CcSEcCtD
Doxepin—Headache—Methotrexate—systemic lupus erythematosus	6.46e-05	0.000214	CcSEcCtD
Doxepin—Nausea—Methotrexate—systemic lupus erythematosus	6.12e-05	0.000203	CcSEcCtD
Doxepin—CHRM4—Signaling Pathways—IL2—systemic lupus erythematosus	6.19e-06	0.000106	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—CDKN1A—systemic lupus erythematosus	6.18e-06	0.000106	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—F2—systemic lupus erythematosus	6.17e-06	0.000105	CbGpPWpGaD
Doxepin—CHRM4—Signaling by GPCR—IL6—systemic lupus erythematosus	6.16e-06	0.000105	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—ALB—systemic lupus erythematosus	6.13e-06	0.000105	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CCL2—systemic lupus erythematosus	6.12e-06	0.000104	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	6.12e-06	0.000104	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—F2—systemic lupus erythematosus	6.11e-06	0.000104	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—PTGS2—systemic lupus erythematosus	6.1e-06	0.000104	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—F2—systemic lupus erythematosus	6.1e-06	0.000104	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CD80—systemic lupus erythematosus	6.07e-06	0.000104	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—PTGS2—systemic lupus erythematosus	6.06e-06	0.000103	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—CDKN1B—systemic lupus erythematosus	6.05e-06	0.000103	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TYK2—systemic lupus erythematosus	6.04e-06	0.000103	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—IL2—systemic lupus erythematosus	5.99e-06	0.000102	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CD80—systemic lupus erythematosus	5.97e-06	0.000102	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CD80—systemic lupus erythematosus	5.96e-06	0.000102	CbGpPWpGaD
Doxepin—HTR2B—Signaling by GPCR—IL6—systemic lupus erythematosus	5.96e-06	0.000102	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	5.94e-06	0.000101	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CD80—systemic lupus erythematosus	5.94e-06	0.000101	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—NOS3—systemic lupus erythematosus	5.93e-06	0.000101	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—IL2—systemic lupus erythematosus	5.92e-06	0.000101	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CD80—systemic lupus erythematosus	5.92e-06	0.000101	CbGpPWpGaD
Doxepin—CHRM5—Signaling by GPCR—IL6—systemic lupus erythematosus	5.89e-06	0.000101	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—EP300—systemic lupus erythematosus	5.88e-06	0.0001	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—NOS3—systemic lupus erythematosus	5.87e-06	0.0001	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CD80—systemic lupus erythematosus	5.86e-06	0.0001	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—MMP9—systemic lupus erythematosus	5.85e-06	9.99e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CD80—systemic lupus erythematosus	5.85e-06	9.97e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TYK2—systemic lupus erythematosus	5.83e-06	9.95e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—CDKN1A—systemic lupus erythematosus	5.83e-06	9.95e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TYK2—systemic lupus erythematosus	5.8e-06	9.9e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—NOS3—systemic lupus erythematosus	5.73e-06	9.77e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—NOS3—systemic lupus erythematosus	5.7e-06	9.72e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—CDKN1B—systemic lupus erythematosus	5.69e-06	9.71e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—MMP9—systemic lupus erythematosus	5.67e-06	9.67e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—F2—systemic lupus erythematosus	5.67e-06	9.67e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TYK2—systemic lupus erythematosus	5.64e-06	9.63e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	5.64e-06	9.63e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CCL2—systemic lupus erythematosus	5.64e-06	9.62e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—ALB—systemic lupus erythematosus	5.63e-06	9.6e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—MMP9—systemic lupus erythematosus	5.61e-06	9.57e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—CDKN1A—systemic lupus erythematosus	5.59e-06	9.53e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.57e-06	9.51e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—IL2—systemic lupus erythematosus	5.57e-06	9.5e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TYK2—systemic lupus erythematosus	5.56e-06	9.48e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—EP300—systemic lupus erythematosus	5.55e-06	9.47e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CCL2—systemic lupus erythematosus	5.55e-06	9.47e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling by GPCR—IL6—systemic lupus erythematosus	5.54e-06	9.46e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—NOS3—systemic lupus erythematosus	5.54e-06	9.45e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CCL2—systemic lupus erythematosus	5.54e-06	9.45e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CCL2—systemic lupus erythematosus	5.52e-06	9.42e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CCL2—systemic lupus erythematosus	5.5e-06	9.39e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—RXRA—systemic lupus erythematosus	5.47e-06	9.34e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—NOS3—systemic lupus erythematosus	5.45e-06	9.31e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CCL2—systemic lupus erythematosus	5.45e-06	9.3e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CCL2—systemic lupus erythematosus	5.43e-06	9.27e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CD80—systemic lupus erythematosus	5.43e-06	9.27e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—NOS3—systemic lupus erythematosus	5.38e-06	9.18e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—EP300—systemic lupus erythematosus	5.37e-06	9.17e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—PTGS2—systemic lupus erythematosus	5.36e-06	9.15e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—EP300—systemic lupus erythematosus	5.32e-06	9.07e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—MMP9—systemic lupus erythematosus	5.27e-06	8.99e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.26e-06	8.97e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—CDKN1A—systemic lupus erythematosus	5.25e-06	8.96e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	5.14e-06	8.77e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TYK2—systemic lupus erythematosus	5.12e-06	8.74e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—TGFB1—systemic lupus erythematosus	5.12e-06	8.73e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.09e-06	8.68e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism of lipids and lipoproteins—EP300—systemic lupus erythematosus	5.07e-06	8.66e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CCL2—systemic lupus erythematosus	5.05e-06	8.62e-05	CbGpPWpGaD
Doxepin—ADRA2C—Metabolism—EP300—systemic lupus erythematosus	5.04e-06	8.6e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TYK2—systemic lupus erythematosus	5.04e-06	8.6e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—VEGFA—systemic lupus erythematosus	5.03e-06	8.59e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TYK2—systemic lupus erythematosus	5.03e-06	8.58e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—IL2—systemic lupus erythematosus	5.03e-06	8.58e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—NOS3—systemic lupus erythematosus	5.03e-06	8.58e-05	CbGpPWpGaD
Doxepin—HRH2—Signaling Pathways—IL6—systemic lupus erythematosus	5.03e-06	8.58e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TYK2—systemic lupus erythematosus	5.01e-06	8.55e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling by GPCR—IL6—systemic lupus erythematosus	5e-06	8.54e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—EP300—systemic lupus erythematosus	5e-06	8.53e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TYK2—systemic lupus erythematosus	5e-06	8.53e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.96e-06	8.46e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TYK2—systemic lupus erythematosus	4.95e-06	8.44e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—NOS3—systemic lupus erythematosus	4.95e-06	8.44e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—NOS3—systemic lupus erythematosus	4.94e-06	8.42e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.93e-06	8.42e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TYK2—systemic lupus erythematosus	4.93e-06	8.42e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—PTGS2—systemic lupus erythematosus	4.92e-06	8.4e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—NOS3—systemic lupus erythematosus	4.92e-06	8.4e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—NOS3—systemic lupus erythematosus	4.9e-06	8.37e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—NOS3—systemic lupus erythematosus	4.86e-06	8.29e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—IL2—systemic lupus erythematosus	4.85e-06	8.28e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—NOS3—systemic lupus erythematosus	4.84e-06	8.27e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling by GPCR—IL6—systemic lupus erythematosus	4.83e-06	8.24e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—IL2—systemic lupus erythematosus	4.83e-06	8.24e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.83e-06	8.23e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling by GPCR—IL6—systemic lupus erythematosus	4.81e-06	8.2e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.8e-06	8.19e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—MMP9—systemic lupus erythematosus	4.76e-06	8.12e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.74e-06	8.09e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.73e-06	8.08e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.72e-06	8.06e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—IL2—systemic lupus erythematosus	4.7e-06	8.01e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling by GPCR—IL6—systemic lupus erythematosus	4.67e-06	7.97e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.67e-06	7.97e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—IL2—systemic lupus erythematosus	4.62e-06	7.89e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.62e-06	7.88e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling by GPCR—IL6—systemic lupus erythematosus	4.6e-06	7.85e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—MMP9—systemic lupus erythematosus	4.59e-06	7.84e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TYK2—systemic lupus erythematosus	4.59e-06	7.82e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.58e-06	7.81e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—MMP9—systemic lupus erythematosus	4.57e-06	7.8e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.55e-06	7.77e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—EP300—systemic lupus erythematosus	4.51e-06	7.7e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—NOS3—systemic lupus erythematosus	4.5e-06	7.68e-05	CbGpPWpGaD
Doxepin—CHRM3—Metabolism—EP300—systemic lupus erythematosus	4.46e-06	7.61e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—MMP9—systemic lupus erythematosus	4.45e-06	7.59e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PPARG—systemic lupus erythematosus	4.43e-06	7.56e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.43e-06	7.56e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—MMP9—systemic lupus erythematosus	4.38e-06	7.47e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.36e-06	7.44e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—EP300—systemic lupus erythematosus	4.36e-06	7.43e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.36e-06	7.43e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—TGFB1—systemic lupus erythematosus	4.34e-06	7.41e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—EP300—systemic lupus erythematosus	4.33e-06	7.39e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PPARG—systemic lupus erythematosus	4.33e-06	7.38e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.29e-06	7.31e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.28e-06	7.3e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.27e-06	7.29e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.26e-06	7.27e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IL2—systemic lupus erythematosus	4.26e-06	7.27e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.25e-06	7.25e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling by GPCR—IL6—systemic lupus erythematosus	4.24e-06	7.24e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—RXRA—systemic lupus erythematosus	4.22e-06	7.2e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—EP300—systemic lupus erythematosus	4.21e-06	7.19e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.21e-06	7.18e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	4.2e-06	7.16e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IL2—systemic lupus erythematosus	4.19e-06	7.16e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IL2—systemic lupus erythematosus	4.18e-06	7.14e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling by GPCR—IL6—systemic lupus erythematosus	4.17e-06	7.12e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IL2—systemic lupus erythematosus	4.17e-06	7.12e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling by GPCR—IL6—systemic lupus erythematosus	4.16e-06	7.1e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IL2—systemic lupus erythematosus	4.16e-06	7.09e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling by GPCR—IL6—systemic lupus erythematosus	4.15e-06	7.08e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—EP300—systemic lupus erythematosus	4.15e-06	7.08e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling by GPCR—IL6—systemic lupus erythematosus	4.14e-06	7.06e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.13e-06	7.04e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IL2—systemic lupus erythematosus	4.12e-06	7.03e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IL2—systemic lupus erythematosus	4.11e-06	7.01e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—VEGFA—systemic lupus erythematosus	4.1e-06	7e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling by GPCR—IL6—systemic lupus erythematosus	4.1e-06	6.99e-05	CbGpPWpGaD
Doxepin—ADRA2A—Metabolism—EP300—systemic lupus erythematosus	4.09e-06	6.99e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling by GPCR—IL6—systemic lupus erythematosus	4.09e-06	6.97e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PPARG—systemic lupus erythematosus	4.08e-06	6.96e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PPARG—systemic lupus erythematosus	4.04e-06	6.9e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—MMP9—systemic lupus erythematosus	4.03e-06	6.88e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	4.02e-06	6.86e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.99e-06	6.81e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—ALB—systemic lupus erythematosus	3.99e-06	6.8e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—MMP9—systemic lupus erythematosus	3.97e-06	6.77e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—MMP9—systemic lupus erythematosus	3.96e-06	6.76e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.95e-06	6.75e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—MMP9—systemic lupus erythematosus	3.95e-06	6.74e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.95e-06	6.73e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—MMP9—systemic lupus erythematosus	3.94e-06	6.71e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.93e-06	6.71e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.93e-06	6.7e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.92e-06	6.69e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.92e-06	6.69e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CDKN1B—systemic lupus erythematosus	3.9e-06	6.65e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—MMP9—systemic lupus erythematosus	3.9e-06	6.65e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—ALB—systemic lupus erythematosus	3.89e-06	6.64e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—MMP9—systemic lupus erythematosus	3.89e-06	6.63e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.88e-06	6.63e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.87e-06	6.61e-05	CbGpPWpGaD
Doxepin—HTR6—Signaling Pathways—IL6—systemic lupus erythematosus	3.85e-06	6.58e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—EP300—systemic lupus erythematosus	3.82e-06	6.53e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL2—systemic lupus erythematosus	3.82e-06	6.51e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—NOS3—systemic lupus erythematosus	3.81e-06	6.51e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling by GPCR—IL6—systemic lupus erythematosus	3.8e-06	6.48e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.79e-06	6.46e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.77e-06	6.43e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—EP300—systemic lupus erythematosus	3.76e-06	6.42e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—EP300—systemic lupus erythematosus	3.75e-06	6.41e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—EP300—systemic lupus erythematosus	3.74e-06	6.39e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—EP300—systemic lupus erythematosus	3.73e-06	6.37e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—NOS3—systemic lupus erythematosus	3.72e-06	6.35e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—EP300—systemic lupus erythematosus	3.69e-06	6.3e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—EP300—systemic lupus erythematosus	3.68e-06	6.29e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—ALB—systemic lupus erythematosus	3.67e-06	6.26e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.66e-06	6.25e-05	CbGpPWpGaD
Doxepin—CHRM4—Signaling Pathways—IL6—systemic lupus erythematosus	3.64e-06	6.2e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—ALB—systemic lupus erythematosus	3.63e-06	6.2e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.62e-06	6.18e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—MMP9—systemic lupus erythematosus	3.61e-06	6.16e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.61e-06	6.15e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—CDKN1A—systemic lupus erythematosus	3.6e-06	6.14e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.56e-06	6.08e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.56e-06	6.07e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.54e-06	6.05e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.53e-06	6.03e-05	CbGpPWpGaD
Doxepin—HTR2B—Signaling Pathways—IL6—systemic lupus erythematosus	3.52e-06	6e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—NOS3—systemic lupus erythematosus	3.51e-06	5.98e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.5e-06	5.97e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.49e-06	5.95e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—PTGS2—systemic lupus erythematosus	3.49e-06	5.95e-05	CbGpPWpGaD
Doxepin—CHRM5—Signaling Pathways—IL6—systemic lupus erythematosus	3.48e-06	5.94e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—NOS3—systemic lupus erythematosus	3.48e-06	5.93e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PPARG—systemic lupus erythematosus	3.45e-06	5.89e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—EP300—systemic lupus erythematosus	3.42e-06	5.84e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—PTGS2—systemic lupus erythematosus	3.4e-06	5.81e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.32e-06	5.67e-05	CbGpPWpGaD
Doxepin—ADRA1D—Signaling Pathways—IL6—systemic lupus erythematosus	3.27e-06	5.59e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.27e-06	5.58e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.26e-06	5.57e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.25e-06	5.55e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.24e-06	5.53e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—VEGFA—systemic lupus erythematosus	3.24e-06	5.53e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.21e-06	5.48e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—PTGS2—systemic lupus erythematosus	3.21e-06	5.47e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—TGFB1—systemic lupus erythematosus	3.2e-06	5.47e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—PTGS2—systemic lupus erythematosus	3.18e-06	5.43e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—ALB—systemic lupus erythematosus	3.11e-06	5.3e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—TGFB1—systemic lupus erythematosus	2.98e-06	5.08e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—NOS3—systemic lupus erythematosus	2.97e-06	5.07e-05	CbGpPWpGaD
Doxepin—ADRA2B—Signaling Pathways—IL6—systemic lupus erythematosus	2.96e-06	5.04e-05	CbGpPWpGaD
Doxepin—CYP2C19—Metabolism—EP300—systemic lupus erythematosus	2.9e-06	4.95e-05	CbGpPWpGaD
Doxepin—HTR1A—Signaling Pathways—IL6—systemic lupus erythematosus	2.85e-06	4.87e-05	CbGpPWpGaD
Doxepin—HTR2C—Signaling Pathways—IL6—systemic lupus erythematosus	2.84e-06	4.84e-05	CbGpPWpGaD
Doxepin—ABCB1—Metabolism—EP300—systemic lupus erythematosus	2.83e-06	4.83e-05	CbGpPWpGaD
Doxepin—ADRA2C—Signaling Pathways—IL6—systemic lupus erythematosus	2.76e-06	4.71e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—PTGS2—systemic lupus erythematosus	2.72e-06	4.64e-05	CbGpPWpGaD
Doxepin—ADRA1B—Signaling Pathways—IL6—systemic lupus erythematosus	2.72e-06	4.64e-05	CbGpPWpGaD
Doxepin—CYP2D6—Metabolism—EP300—systemic lupus erythematosus	2.67e-06	4.55e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PPARG—systemic lupus erythematosus	2.67e-06	4.55e-05	CbGpPWpGaD
Doxepin—CYP2C9—Metabolism—EP300—systemic lupus erythematosus	2.64e-06	4.51e-05	CbGpPWpGaD
Doxepin—DRD2—Signaling Pathways—IL6—systemic lupus erythematosus	2.51e-06	4.27e-05	CbGpPWpGaD
Doxepin—HTR2A—Signaling Pathways—IL6—systemic lupus erythematosus	2.46e-06	4.21e-05	CbGpPWpGaD
Doxepin—HRH1—Signaling Pathways—IL6—systemic lupus erythematosus	2.46e-06	4.2e-05	CbGpPWpGaD
Doxepin—CHRM1—Signaling Pathways—IL6—systemic lupus erythematosus	2.45e-06	4.18e-05	CbGpPWpGaD
Doxepin—CHRM3—Signaling Pathways—IL6—systemic lupus erythematosus	2.44e-06	4.17e-05	CbGpPWpGaD
Doxepin—CHRM2—Signaling Pathways—IL6—systemic lupus erythematosus	2.42e-06	4.13e-05	CbGpPWpGaD
Doxepin—ADRA1A—Signaling Pathways—IL6—systemic lupus erythematosus	2.41e-06	4.12e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—ALB—systemic lupus erythematosus	2.4e-06	4.09e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—NOS3—systemic lupus erythematosus	2.29e-06	3.91e-05	CbGpPWpGaD
Doxepin—CYP1A2—Metabolism—EP300—systemic lupus erythematosus	2.26e-06	3.86e-05	CbGpPWpGaD
Doxepin—ADRA2A—Signaling Pathways—IL6—systemic lupus erythematosus	2.24e-06	3.83e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—PTGS2—systemic lupus erythematosus	2.1e-06	3.58e-05	CbGpPWpGaD
Doxepin—CYP3A4—Metabolism—EP300—systemic lupus erythematosus	1.74e-06	2.98e-05	CbGpPWpGaD
